title: Butyrate-producing Clostridium cluster XIVa species specifically colonize mucins in an in vitro gut model.
abstract: The human gut is colonized by a complex microbiota with multiple benefits. Although the surface-attached, mucosal microbiota has a unique composition and potential to influence human health, it remains difficult to study in vivo. Therefore, we performed an in-depth microbial characterization (human intestinal tract chip (HITChip)) of a recently developed dynamic in vitro gut model, which simulates both luminal and mucosal gut microbes (mucosal-simulator of human intestinal microbial ecosystem (M-SHIME)). Inter-individual differences among human subjects were confirmed and microbial patterns unique for each individual were preserved in vitro. Furthermore, in correspondence with in vivo studies, Bacteroidetes and Proteobacteria were enriched in the luminal content while Firmicutes rather colonized the mucin layer, with Clostridium cluster XIVa accounting for almost 60% of the mucin-adhered microbiota. Of the many acetate and/or lactate-converting butyrate producers within this cluster, Roseburia intestinalis and Eubacterium rectale most specifically colonized mucins. These 16S rRNA gene-based results were confirmed at a functional level as butyryl-CoA:acetate-CoA transferase gene sequences belonged to different species in the luminal as opposed to the mucin-adhered microbiota, with Roseburia species governing the mucosal butyrate production. Correspondingly, the simulated mucosal environment induced a shift from acetate towards butyrate. As not only inter-individual differences were preserved but also because compared with conventional models, washout of relevant mucin-adhered microbes was avoided, simulating the mucosal gut microbiota represents a breakthrough in modeling and mechanistically studying the human intestinal microbiome in health and disease. Finally, as mucosal butyrate producers produce butyrate close to the epithelium, they may enhance butyrate bioavailability, which could be useful in treating diseases, such as inflammatory bowel disease.
authors.affiliation: Laboratory of Microbial Ecology and Technology (LabMET), Ghent University, Ghent, Belgium.
authors.forename: Pieter
authors.initials: P
authors.lastname: Van den Abbeele
authors.forename: Clara
authors.initials: C
authors.lastname: Belzer
authors.forename: Margot
authors.initials: M
authors.lastname: Goossens
authors.forename: Michiel
authors.initials: M
authors.lastname: Kleerebezem
authors.forename: Willem M
authors.initials: WM
authors.lastname: De Vos
authors.forename: Olivier
authors.initials: O
authors.lastname: Thas
authors.forename: Rosemarie
authors.initials: R
authors.lastname: De Weirdt
authors.forename: Frederiek-Maarten
authors.initials: FM
authors.lastname: Kerckhof
authors.forename: Tom
authors.initials: T
authors.lastname: Van de Wiele
mesh_terms: D000214:Acyl Coenzyme A / Q000378:metabolism; D000328:Adult; D002087:Butyrates / Q000378:metabolism; D003013:Clostridium / Q000145:classification / Q000235:genetics / Q000302:isolation & purification* / Q000502:physiology*; D003106:Colon / Q000737:chemistry / Q000382:microbiology*; D017753:Ecosystem; D005243:Feces / Q000382:microbiology; D041981:Gastrointestinal Tract / Q000382:microbiology*; D006801:Humans; D007413:Intestinal Mucosa / Q000382:microbiology; D008297:Male; D008954:Models, Biological; D009010:Monte Carlo Method; D009077:Mucins / Q000378:metabolism; D012336:RNA, Ribosomal, 16S / Q000235:genetics
chemical_list: D000214:Acyl Coenzyme A; D002087:Butyrates; D009077:Mucins; D012336:RNA, Ribosomal, 16S; C024343:butyryl-coenzyme A